Curanex Pharmaceuticals Inc CURX
Set alert
5.85 USD +0.56 +10.59%
At close · Nov 2
5.85 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
5.40 Day range 5.85
3.66 52-week range 13.56
- YTD
- -11.63%
- 1 year
- -56.86%
- Open
- 5.47
- Prev close
- 5.29
- Mkt cap
- 9.17M
- Vol
- 3.35K
- Avg vol
- 22.07K
- EPS
- -8.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.40
- High
- 5.85
5D chart
Signals (16)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 4:00 PM | 10 hours ago |
| RSI: Overbought | Nov 2, 1:45 PM | 12 hours ago |
| RSI: Overbought | Nov 2, 1:15 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 11:50 AM | 14 hours ago |
| SMA: Bullish | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 10:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:30 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:35 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 4 days ago |
Financial health
Altman Z-Score
10.38 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -2.2×
FY 2022 5y median -2908× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 0.8×
FY 2022 5y median 111× FY 2025
P/FCF -0.9×
FY 2022 5y median -101× FY 2025
EV/EBITDA -1.1×
FY 2022 5y median -192× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -111.9%
FY 2022 5y median -0.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -37.7%
FY 2022 5y median -34.8% FY 2025
ROIC -36.7%
FY 2022 5y median -34.4% FY 2025
ROA -36.5%
FY 2022 5y median -31.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -1061.2%
FY 2022 FY 2025
EPS (diluted) -1046.2%
FY 2022 FY 2025
Free Cash Flow -1787.1%
FY 2022 FY 2025
Financial Health
Current Ratio 81.9×
FY 2022 5y median 20.4× FY 2025
Quick Ratio 81.9×
FY 2022 5y median 20.4× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2022 5y median 0.8× FY 2025
Interest Coverage -497×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31